½ÃÀ庸°í¼­
»óǰÄÚµå
1441469

»ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ±Ô¸ð : À¯Çü, ¿ëµµ, ÄÄÆ÷³ÍÆ®, ¼Ö·ç¼Ç - Áö¿ªÀû Àü¸Á, °æÀï Àü·«, ºÎ¹® ¿¹Ãø(-2033³â)

Life Science Software Market Size- By Type, By Application, By Component, By Solutions - Regional Outlook, Competitive Strategies and Segment Forecast to 2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: SPER Market Research Pvt. Ltd. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 234 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

»ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ±Ô¸ð´Â ¿¹Ãø ±â°£ Áß 13.11%ÀÇ CAGR·Î ÃßÀÌÇϸç, 2033³â¿¡´Â 647¾ï 1,000¸¸ ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀº COVID-19ÀÇ À¯Çà¿¡ ÀÇÇØ Å« ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ÀÌ ¹ÙÀÌ·¯½º¿¡ ´ëÇÑ Ä¡·á¹ý ¹× ¹é½ÅÀÇ °³¹ßÀÌ ±Þ¼±¹«°¡ µÇ°í ÀÖÀ¸¹Ç·Î Drug Discovery, À¯ÀüüÇÐ, ÀÓ»ó½ÃÇèÀ» Áö¿øÇÏ´Â ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ´ë¸é ȸÀǰ¡ ±ÝÁöµÇ¾ú±â ¶§¹®¿¡ ¿ø°Ý±Ù¹« ¹× Çù¾÷ ÅøÀÌ ÇÊ¿äÇϸç, Ŭ¶ó¿ìµå ±â¹Ý Ç÷§Æû ¹× ¿Â¶óÀÎ Çù¾÷ ÅøÀÇ µµÀÔÀÌ ½Ã±ÞÇØÁö°í ÀÖ½À´Ï´Ù.

¼¼°èÀÇ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ¿µÇâ¿äÀÎ ¹× ½ÃÀå ±âȸÀÇ ºÐ¼®, ½ÃÀå ±Ô¸ðÀÇ ÃßÀÌ¡¤¿¹Ãø, °¢Á¾ ±¸ºÐ¡¤Áö¿ªº° »ó¼¼ ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ÀÇ °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ¿ªÇÐ

  • ÃËÁø¿äÀΡ¤¾ïÁ¦¡¤±âȸ¡¤°úÁ¦ ºÐ¼®
  • ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ

Á¦5Àå ½ÃÀå º¯¼ö¿Í Àü¸Á

  • SWOT ºÐ¼®
  • PESTEL ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • È÷Æ®¸Ê ºÐ¼®

Á¦6Àå °æÀï ±¸µµ

  • Á¦Á¶ ±â¹Ý ºÐÆ÷¡¤ÆÇ¸Å ¿¡¾î¸®¾î¡¤Á¦Ç° À¯Çü
  • M&A¡¤Á¦ÈÞ¡¤Á¦Ç° ¹ß¸Å¡¤Çù·Â

Á¦7Àå ¼¼°èÀÇ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : À¯Çüº°

  • ¼¼°è ½ÃÀå ±Ô¸ðÀÇ Á¡À¯À²¡¤¿¹Ãø
  • ±â¼úÀû
  • ¿¹ÃøÀû
  • ó¹æÀû

Á¦8Àå ¼¼°èÀÇ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ¿ëµµº°

  • ¼¼°è ½ÃÀå ±Ô¸ðÀÇ Á¡À¯À²¡¤¿¹Ãø
  • ÄÄÇöóÀ̾ð½º
  • ¸¶ÄÉÆÃ
  • R&D
  • ¾à¹°°¨½Ã
  • SCM

Á¦9Àå ¼¼°èÀÇ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

  • ¼¼°è ½ÃÀå ±Ô¸ðÀÇ Á¡À¯À²¡¤¿¹Ãø
  • ¼ÒÇÁÆ®¿þ¾î
  • ¼­ºñ½º

Á¦10Àå ¼¼°èÀÇ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ¼Ö·ç¼Çº°

  • ¼¼°è ½ÃÀå ±Ô¸ðÀÇ Á¡À¯À²¡¤¿¹Ãø
  • Ŭ¶ó¿ìµå ±â¹Ý
  • ¿ÂÇÁ·¹¹Ì½º

Á¦11Àå ¼¼°èÀÇ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ¿¹Ãø

  • ½ÃÀå ±Ô¸ð¡¤½ÃÀå Á¡À¯À²ÀÇ ÃßÀÌ¡¤¿¹Ãø

Á¦12Àå ¼¼°èÀÇ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : À¯Çüº°

  • ½ÃÀå ±Ô¸ð¡¤½ÃÀå Á¡À¯À²ÀÇ ÃßÀÌ¡¤¿¹Ãø

Á¦13Àå ¼¼°èÀÇ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ¿ëµµº°

  • ½ÃÀå ±Ô¸ð¡¤½ÃÀå Á¡À¯À²ÀÇ ÃßÀÌ¡¤¿¹Ãø

Á¦14Àå ¼¼°èÀÇ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

  • ½ÃÀå ±Ô¸ð¡¤½ÃÀå Á¡À¯À²ÀÇ ÃßÀÌ¡¤¿¹Ãø

Á¦15Àå ¼¼°èÀÇ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ¼Ö·ç¼Çº°

  • ½ÃÀå ±Ô¸ð¡¤½ÃÀå Á¡À¯À²ÀÇ ÃßÀÌ¡¤¿¹Ãø

Á¦16Àå ¼¼°èÀÇ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : Áö¿ªº°

  • ½ÃÀå ±Ô¸ð¡¤½ÃÀå Á¡À¯À²ÀÇ ÃßÀÌ¡¤¿¹Ãø
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • À¯·´
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ºÏ¹Ì
  • ¶óƾ¾Æ¸Þ¸®Ä«

Á¦17Àå ±â¾÷ °³¿ä

  • Allscripts Healthcare LLC
  • Cerner Corporation
  • Cognizant
  • CPSI
  • Elinext
  • EPIC System Corporation
  • INFOR
  • Jag Products LLC
  • Meta
  • Oracle
  • ±âŸ

Á¦18Àå ¾à¾î ¸®½ºÆ®

Á¦19Àå Âü°í ¸µÅ©

Á¦20Àå °á·Ð

Á¦21Àå Á¶»ç ¹üÀ§

KSA 24.03.12

Life Science Software Market Introduction and Overview

According to SPER market research, 'Life Science Software Market - By Type, By Application, By Component, By Solution- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Global Life Science Software Market is predicted to reach USD 64.71 billion by 2033 with a CAGR of 13.11%.

Life science software includes a range of tools for standardizing workflow and document management in the biopharmaceutical, medical technology, generics, and clinical care sectors. These programs allow businesses to capture, store, and preserve data using images and text. There are various types of life science software available, such as drug identification and validation, laboratory management, clinical trial management, and medical device development.

Furthermore, the global market for life science software has been significantly affected by the COVID-19 pandemic. Because of the urgency of developing treatments and vaccines for the virus, there is an increased demand for software solutions that aid in drug discovery, genomics, and clinical trials. The ban on in-person meetings necessitated remote work and collaboration tools, hastening the adoption of cloud-based platforms and online collaboration tools.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Type, By Application, By Component, By Solution

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Allscripts Healthcare LLC, Cerner Corporation , Cognizant, CPSI , Elinext , EPIC Systems Corporation, INFOR, Jag products LLC ,Meta, Oracle

Global Life Science Software Market Segmentation:

By Type: Based on the Type, Global Life Science Software Market is segmented as; Descriptive, Predictive and Prescriptive.

By Application: Based on the Application, Global Life Science Software Market is segmented as; Compliance, Marketing, R & D, Pharmacovigilance and SCM.

By Component: Based on the Component, Global Life Science Software Market is segmented as; Software and Services.

By Solutions: Based on the Solutions, Global Life Science Software Market is segmented as; Cloud- Based and On- Premises.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impacts of the Global Life Science Software Market

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTER's Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Life Science Software Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Life Science Software Market

7. Global Life Science Software Market, By Type (USD Million)

  • 7.1. Global Life Science Software Market Value Share and Forecast, By Type, 2024-2033
  • 7.2. Descriptive
  • 7.3. Predictive
  • 7.4. Prescriptive

8. Global Life Science Software Market, By Application (USD Million)

  • 8.1. Global Life Science Software Market Value Share and Forecast, By Application, 2024-2033
  • 8.2. Compliance
  • 8.3. Marketing
  • 8.4. R &D
  • 8.5. Pharmacovigilance
  • 8.6. SCM

9. Global Life Science Software Market, By Component (USD Million)

  • 9.1. Global Life Science Software Market Value Share and Forecast, By Component, 2024-2033
  • 9.2. Software
  • 9.3. Services

10. Global Life Science Software Market, By Solution (USD Million)

  • 10.1. Global Life Science Software Market Value Share and Forecast, By Solution, 2024-2033
  • 10.2. Cloud- Based
  • 10.3. On- Premises

11. Global Life Science Software Market Forecast, 2020-2033 (USD Million)

  • 11.1. Global Life Science Software Market Size and Market Share

12. Global Life Science Software Market, By Type, 2020-2033 (USD Million)

  • 12.1. Global Life Science Software Market Size and Market Share By Type (2020-2026)
  • 12.2. Global Life Science Software Market Size and Market Share By Type (2027-2033)

13. Global Life Science Software Market, By Application, 2020-2033 (USD Million)

  • 13.1. Global Life Science Software Market Size and Market Share By Application (2020-2026)
  • 13.2. Global Life Science Software Market Size and Market Share By Application (2027-2033)

14. Global Life Science Software Market, By Component, 2020-2033 (USD Million)

  • 14.1. Global Life Science Software Market Size and Market Share By Component (2020-2026)
  • 14.2. Global Life Science Software Market Size and Market Share By Component (2027-2033)

15. Global Life Science Software Market, By Solution, 2020-2033 (USD Million)

  • 15.1. Global Life Science Software Market Size and Market Share By Solution (2020-2026)
  • 15.2. Global Life Science Software Market Size and Market Share By Solution (2027-2033)

16. Global Life Science Software Market, By Region, 2020-2033 (USD Million)

  • 16.1. Global Life Science Software Market Size and Market Share By Region (2020-2026)
  • 16.2. Global Life Science Software Market Size and Market Share By Region (2027-2033)
  • 16.3. Asia-Pacific
    • 16.3.1. Australia
    • 16.3.2. China
    • 16.3.3. India
    • 16.3.4. Japan
    • 16.3.5. South Korea
    • 16.3.6. Rest of Asia-Pacific
  • 16.4. Europe
    • 16.4.1. France
    • 16.4.2. Germany
    • 16.4.3. Italy
    • 16.4.4. Spain
    • 16.4.5. United Kingdom
    • 16.4.6. Rest of Europe
  • 16.5. Middle East and Africa
    • 16.5.1. Kingdom of Saudi Arabia
    • 16.5.2. United Arab Emirates
    • 16.5.3. Rest of Middle East & Africa
  • 16.6. North America
    • 16.6.1. Canada
    • 16.6.2. Mexico
    • 16.6.3. United States
  • 16.7. Latin America
    • 16.7.1. Argentina
    • 16.7.2. Brazil
    • 16.7.3. Rest of Latin America

17. Company Profile

  • 17.1. Allscripts Healthcare LLC
    • 17.1.1. Company details
    • 17.1.2. Financial outlook
    • 17.1.3. Product summary
    • 17.1.4. Recent developments
  • 17.2. Cerner Corporation
    • 17.2.1. Company details
    • 17.2.2. Financial outlook
    • 17.2.3. Product summary
    • 17.2.4. Recent developments
  • 17.3. Cognizant
    • 17.3.1. Company details
    • 17.3.2. Financial outlook
    • 17.3.3. Product summary
    • 17.3.4. Recent developments
  • 17.4. CPSI
    • 17.4.1. Company details
    • 17.4.2. Financial outlook
    • 17.4.3. Product summary
    • 17.4.4. Recent developments
  • 17.5. Elinext
    • 17.5.1. Company details
    • 17.5.2. Financial outlook
    • 17.5.3. Product summary
    • 17.5.4. Recent developments
  • 17.6. EPIC System Corporation
    • 17.6.1. Company details
    • 17.6.2. Financial outlook
    • 17.6.3. Product summary
    • 17.6.4. Recent developments
  • 17.7. INFOR
    • 17.7.1. Company details
    • 17.7.2. Financial outlook
    • 17.7.3. Product summary
    • 17.7.4. Recent developments
  • 17.8. Jag Products LLC
    • 17.8.1. Company details
    • 17.8.2. Financial outlook
    • 17.8.3. Product summary
    • 17.8.4. Recent developments
  • 17.9. Meta
    • 17.9.1. Company details
    • 17.9.2. Financial outlook
    • 17.9.3. Product summary
    • 17.9.4. Recent developments
  • 17.10. Oracle
    • 17.10.1. Company details
    • 17.10.2. Financial outlook
    • 17.10.3. Product summary
    • 17.10.4. Recent developments
  • 17.11. Others

18. List of Abbreviations

19. Reference Links

20. Conclusion

21. Research Scope

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦